CASP1 and Cognitive impairment: In addition, a single clinically relevant dose of ketamine (7 mg/kg) can induce an inflammatory reaction and cognitive impairment in the hippocampus of developing rats, which is related to activation of the NLRP3 inflammatory body/caspase-1 axis [101, 102].